(Afyon Kocatepe Üniversitesi)
(Ege Üniversitesi)
(Ege Üniversitesi)
Rıdvan IŞIK
(Ege Üniversitesi)
Yıl: 2017Cilt: 20Sayı: 2ISSN: 1309-3843 / 1307-7384Sayfa Aralığı: 71 - 76İngilizce

83 0
Effects of Complete Decongestive Therapy on Primary and Secondary Lymphedema of Lower Extremity
Objective: To investigate the outcome of complete decongestive therapy (CDT) on primary and secondary lymphedema of the lower limb (LL). Material and Methods: Included 40 patients with LL lymphedema were retrospectively analyzed. Age, gender, diagnosis, extremity volume, subtype of lymphedema, radiotherapy chemotherapy history of all the patients were noted. The amount of limb edema was calculated with volumetric measurements before and after the treatment for each patient. Bilateral circumferential measurements were carried out at the level of metatarsophalangeal joints, mid-dorsum of the feet, ankle and every 10 cm till the inguinal level. Afterwards, a computer program was used to convert these values into limb volumes in milliliters. Results: It is found out that CDT causes a significant improvement in the average volume of the LL p=0.01). Nonetheless, the statistics showed significance (p= 0.008) only in secondary group. Moreover, there were no significant difference in percentage changes betwen both groups showed no significance after treatment (p>0.05). We also determined that initial volumes were significantly correlated with volume reduction rates (r= 0.670, p= 0.000). Conclusion: CDT is an effective, safe and well tolerated treatment for lymphedema of lower extremity limb. There was significant improvement in clinical outcomes particularly in secondary lymphedema group; whereas, percentage change in limb volumes of both groups showed no significance. Hence, our results suggest that the volume reductive effects of CDT is not correlated with the lymphedema (ethiology). Future studies comprising greater population with various ethiology are needed.
Fen > Tıp > Genel ve Dahili Tıp
Fen > Tıp > Rehabilitasyon
DergiAraştırma MakalesiErişime Açık
  • Zaleska M, Olszewski WL, Durlik M. The effectiveness of intermittent pneumatic compression in long-term therapy of lymphedema of lower limbs. Lymphat Res Biol 2014;12(2): 103-9.
  • Greene R, Fowler R. Physical therapy management of primary lymphedema in the lower extremities: A case report. Physiother Theory Pract 2010;26(1):62-8.
  • Rockson G. Lymphatics in the digestive system: physiology, health and disease. Ann NY Acad Sci 2010;1207:E2-E6.
  • Stanisic MG, Gabriel M, Pawlaczyk K. Intensive decongestive treatment restores ability to work in patients with advanced forms of primary and secondary lower extremity lymphoedema. Phlebology 2012;27(7):347-51.
  • McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer 2005;104(3):457-66.
  • Leung EY, Tirlapur SA, Meads C. The management of secondary lower limb lymphoedema in cancer patients: a systematic review. Palliat Med 2015;29(2):112-9.
  • Position statement of the National Lymphedema Network. TOPIC: the diagnosis and treatment of lymphedema. National Lymphedema Network 2011;1-19. http://www.lymphnet.org/pdfDocs/nlntreatment.pdf
  • Mayrovitz HN. The standard of care for lymphedema: current concepts and physiological considerations. Lymphat Res Biol 2009;7(2): 101-8.
  • Kim SJ, Park YD. Effects of complex decongestive physiotherapy on the oedema and the quality of life of lower unilateral lymphoedema following treatment for gynecological cancer. Eur J Cancer Care (Engl) 2008;17(5):463-8.
  • Carmeli E, Bartoletti R. Retrospective trial of complete decongestive physical therapy for lower extremity secondary lymphedema in melanoma patients. Support Care Cancer 2011;19(1):141-7.
  • Liao SF, Li SH, Huang HY. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of response to CDP in lower limb lymphedema (LLL) after pelvic cancer treatment. Gynecol Oncol 2012;125(3): 712-5.
  • Noh S, Hwang JH, Yoon TH, Chang HJ, Chu IH, Kim JH. Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients. Ann Rehabil Med 2015;39(3):347-59.
  • Leard T, Barrett C. Successful Management of Severe Unilateral Lower Extremity Lymphedema in an Outpatient Setting. Phys Ther 2015;95(9):1295-306.
  • Hodgson P, Towers A, Keast DH, Kennedy A, Pritzker R, Allen J. Lymphedema in Canada: a qualitative study to help develop a clinical, research, and education strategy. Curr Oncol 2011;18(6):e260-4.
  • Fu MR, Kang Y. Psychosocial impact of living with cancer-related lymphedema. Semin Oncol Nurs 2013;29(1):50-60.
  • Oremus M, Dayes I, Walker K, Raina P. Systematic review: conservative treatments for secondary lymphedema. BMC Cancer 2012; 12:6.
  • McNeely ML, Peddle CJ, Yurick JL, Dayes IS, Mackey JR. Conservative and dietary interventions for cancer-related lymphedema: a systematic review and meta-analysis. Cancer 2011;117(6):1136-48.
  • Deura I, Shimada M, Hirashita K, Sugimura M, Sato S, Sato S, et al. Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy. Int J Clin Oncol 2015;20(3):556-60.
  • Cemal Y, Jewell S, Albornoz CR, Pusic A, Mehrara BJ. Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema. Lymphat Res Biol 2013;11(1): 14-9.
  • Yamamoto R, Yamamoto T. Effectiveness of the treatment-phase of two-phase complex decongestive physiotherapy for the treatment of extremity lymphedema. Int J Clin Oncol 2007;12(6):463-8.
  • Szuba A, Cooke JP, Yousuf S, Rockson SG. Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med 2000;109(4):296-300.
  • Ko DS, Lerner R, Klose G, Cosimi AB. Effective treatment of lymph¬edema of the extremities. Arch Surg 1998;133(4):452-8.
  • Boris M, Weindorf S, Lasinkski S. Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology (Williston Park) 1997;11(1):99-109.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.